You are here

Santen

Omlonti Granted FDA Approval in Glaucoma and Ocular Hypertension

Xtalks

Mon, 10/10/22 - 10:54 am

UBE Corporation

ocular hypertension

Verily plans digital ophthalmology joint venture with Santen

Pharmaforum

Thu, 02/6/20 - 11:35 pm

digital ophthalmology

Positive trial results push Santen eye drug toward approval

BioPharma Dive

Tue, 11/29/16 - 05:36 pm

clinical trials

Merck Sells Eye Products to Santen

Bloomberg

Tue, 05/13/14 - 07:54 am

Merck licenses Santen eye drug for undisclosed sum

Yahoo/AP

Wed, 04/15/09 - 08:59 am